CC(C)(C)C1CCC2c3c([nH]c4ccccc34)C3C(=O)N(c4ccc([N+](=O)[O-])cc4)C(=O)C3C2C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?